Shows
infektiopodInfektiopod 91: Stenotrophomonas maltophilia with Pranita Tamma (english)This special episode of Infektiopod is in English and features Dr. Pranita Tamma, Professor at the Johns Hopkins University School of Medicine. She is the first author of the IDSA Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections, which we covered at-length in Episode 86 and Episode 87. Dr. Tamma is an expert on … „Infektiopod 91: Stenotrophomonas maltophilia with Pranita Tamma (english)“ weiterlesen2025-01-2943 min
Editors in ConversationNew generation B-lactam/B-lactamase inhibitors: TaniborbactamA new generation of B-lactamase inhibitors is likely to reach the market in the upcoming year. These broad-spectrum inhibitors exhibit activity against the most feared class B metallo-B-lactamases maintaining the inhibition of other enzymes. Recently AAC has published three papers that describe the mechanistic bases of taniborbactam resistance among metallo-enzymes. This knowledge is crucial to understand the limitation of these compounds in clinical practice. Today, we will discuss this topic with some of the authors of the mentioned papers. Welcome to the editors in conversation. Topics discussed: The activity and chemical basis of new generation B-lactamase...2024-01-1347 minEditors in ConversationAAC Launches a New Section Focused On Antimicrobial StewardshipIn response to the global burden of antimicrobial resistance (AMR) and the critical role antimicrobial stewardship plays in optimizing antibiotic use and reducing the subsequent emergence of AMR, Antimicrobial Agents and Chemotherapy is excited to add a new section to the journal focused on antimicrobial stewardship studies. Combatting the devastating burden of AMR requires novel, multipronged approaches from clinicians and scientists alike. Launching this new section is an important step in disseminating cutting-edge research that will have notable implications in the global fight against antimicrobial-resistant pathogens. Topics discussed: The role of antimicrobial stewardship in preventing emerging...2023-08-0437 min
FebrilePièce de (Gram-negative) Resistance, Part 2: CREWelcome to Part 2 of this pair of episodes on management of antimicrobial resistant Gram-negative infections!! Drs. Hawra Al-Lawati and Pranita Tamma walk through the alphabet soup of CRE with 2 mini-cases. Don’t miss the prior episode (Febrile #76) for more on AmpC and ESBL!You can find the most updated 2023 IDSA Guidance at this link: https://www.idsociety.org/practice-guideline/amr-guidanceEpisodes | Consult Notes | Subscribe | Twitter | Merch | febrilepodcast@gmail.com2023-07-1033 min
FebrilePièce de (Gram-negative) Resistance, Part 1: AmpC, ESBLWelcome to Part 1 of this pair of episodes on management of antimicrobial resistant Gram-negative infections!! Drs. Hawra Al-Lawati and Pranita Tamma walk through the alphabet soup of AmpC and ESBL with 3 mini-casesYou can find the most updated 2023 IDSA Guidance at this link: https://www.idsociety.org/practice-guideline/amr-guidanceEpisodes | Consult Notes | Subscribe | Twitter | Merch | febrilepodcast@gmail.com2023-06-2653 min
Ta de ClinicagemTdC 190: KPC e outras carbapenemases🚨 www.tadeclinicagem.com.br/guia - Conheça o Guia TdC com 7 dias grátis 🚨
🔴 Junte-se aos mais de 3.000 assinantes. Assine o Guia, ganhe tempo e atualize-se sem esforço.
🟠 Um serviço de revisão e atualização continuados em clínica médica. A informação que você precisa, do jeito que você prefere.
📚 Confira agora mesmo a edição aberta do Guia TdC sobre a nova diretriz de Insuficiência Cardíaca (IC) da American Heart Association (AHA): https://www.tadeclinicagem.com.br/guia/2/diretriz-de-insuficiencia-cardiaca-aha-2022/.
REFERÊNCIAS:
1. Bush, Karen, and Patricia A Bradford. “Epidemiology of β-Lactamase-Producing Pathogens...2023-06-1527 min
BreakpointsA Conversation with the Authors of IDSA Guidance on Treatment of AmpC, CRAB, and StenotrophomonasDrs. Pranita Tamma (@pranita_tamma) and Sam Aitken (@OncIDPharmd) are BACK on the podcast this week with Dr. Erin McCreary (@ErinMcCreary) to discuss IDSA guidance on AmpC producers, carbapenem-resistant Acinetobacter baumanii, and Stenotrophomonas as part of our series on gram-negative bacteria. Listen as the panelists navigate the hot mess that is the CRAB treatment landscape, have a minocycline appreciation moment (we stan for Steno Sam!), and throw down some bar trivia in an "I Feel Nerdy" segment that you don't want to miss.
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
Twitter: @S...2022-01-281h 13BreakpointsA Conversation with the Authors of IDSA Guidance on Treatment of ESBL, CRE, and DTR PseudomonasDrs. Pranita Tamma (@pranita_tamma) and Sam Aitken (@OncIDPharmd), authors of the IDSA Guidance on gram-negative resistance, join Dr. Erin McCreary (@ErinMcCreary) for this exquisitely good episode to discuss the soon-to-be-updated guidance on treatment of ESBL producers, CRE producers, and difficult to treat (DTR) Pseudomonas.
Learn more about the Society of Infectious Diseases Pharmacists:
Website: https://sidp.org/About
Twitter: @SIDPharm (https://twitter.com/SIDPharm)
Instagram: @SIDPharm (https://www.instagram.com/sidpharm/)
Facebook: https://www.facebook.com/sidprx
LinkedIn: https://www.linkedin.com/company/sidp/
References:
PRO: Testing for ESBL production is necessary for ce...2022-01-211h 15Editors in Conversationβ-lactam/β-lactamase inhibitor combinations (AAC ed.)The development of β-lactam/β-lactamase inhibitors seems to be expanding rapidly and promise to be the best short-term strategy against the most recalcitrant Gram-negative pathogens. In this podcast, we will discuss the current state of the art in this field. Objectives: • Discuss how the discovery of β-lactam/β-lactam inhibitors has evolved • Review the current state-of-the-art of developing of novel β-lactam/β-lactamase inhibitors • Analyze the current and future clinical applications of these drugs against major antimicrobial-resistant pathogens. Guests: Robert Bonomo, MD. Professor and Associate Chief of Staff for Academic Affairs; Director Cas...2021-05-0746 min